IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington
01. Mai 2024 08:30 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces that...
GRI Bio Announces Pricing of $5.5 Million Public Offering
02. Februar 2024 08:00 ET
|
GRI Bio, Inc.
LA JOLLA, CA, Feb. 02, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell...
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
18. Mai 2021 16:05 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD., May 18, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve...
Vallon Pharmaceuticals to Present at the Q2 Virtual Investor Summit
07. Mai 2021 08:05 ET
|
Vallon Pharmaceuticals Inc.
Live video webcast with David Baker, President and CEO of Vallon on Tuesday, May 18, 2021 at 4:15 PM ET PHILADELPHIA, PA, May 07, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ:...
Vallon Pharmaceuticals Announces Closing of Initial Public Offering
12. Februar 2021 15:30 ET
|
Vallon Pharmaceuticals Inc.
PHILADELPHIA, PA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ: VLON) (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
Processa Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
11. Januar 2021 10:50 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to...
Processa Pharmaceuticals Closes $19.2 Million Public Offering
06. Oktober 2020 16:05 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products that are intended...
iTeos Therapeutics to Present at UBS Global Healthcare Conference
13. Mai 2019 08:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics to Present at UBS Global Healthcare Conference Gosselies, Belgium and Cambridge, MA – May 13, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company developing novel...